Tech Company Financing Transactions
Bridge Laboratories Funding Round
GGV Capital and WI Harper invested in a $35 million Series B funding round for Bridge Laboratories. The round was announced on 2/13/2007.
Transaction Overview
Company Name
Announced On
2/13/2007
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors
GGV Capital (Helen Wong)
Proceeds Purpose
The capital raised will be used to accelerate growth of Bridge's preclinical operations in China, as well as to support M&A activities, including its recent acquisition of the Preclinical Division of Gene Logic Inc. of Gaithersburg, Maryland in December, 2006. In addition, Bridge plans to initiate construction of a second vivarium in Beijing shortly.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
6 Venture 250
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
Bridge is a US-headquartered preclinical contract-research organization (CRO) focusing on providing US-regulatory compliant drug development services in the US and Asia. Currently Bridge operates the largest vivarium and US-level compliant pharmaceutical drug testing lab in China.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tom Oakley
Browse more venture capital transactions:
Prev: 2/13/2007: LiveOps venture capital transaction
Next: 2/13/2007: Locus Pharmaceuticals venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs